260 reports of this reaction
2.6% of all VARENICLINE reports
#7 most reported adverse reaction
NASAL DISCOMFORT is the #7 most commonly reported adverse reaction for VARENICLINE, manufactured by Oyster Point Pharma, Inc.. There are 260 FDA adverse event reports linking VARENICLINE to NASAL DISCOMFORT. This represents approximately 2.6% of all 10,186 adverse event reports for this drug.
Patients taking VARENICLINE who experience nasal discomfort should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NASAL DISCOMFORT is a less commonly reported adverse event for VARENICLINE, but still significant enough to appear in the safety profile.
In addition to nasal discomfort, the following adverse reactions have been reported for VARENICLINE:
The following drugs have also been linked to nasal discomfort in FDA adverse event reports:
NASAL DISCOMFORT has been reported as an adverse event in 260 FDA reports for VARENICLINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NASAL DISCOMFORT accounts for approximately 2.6% of all adverse event reports for VARENICLINE, making it a notable side effect.
If you experience nasal discomfort while taking VARENICLINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.